Ambu A/S
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$943Kgeneral payments (2019-2025)
$22Kresearch payments (2019-2025)
217clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Jonathan Kurman | Milwaukee, WI | Pulmonary Disease | $112,003.71 |
| Sonali Sethi | New York, NY | Pulmonary Disease | $64,138.97 |
| Douglas Hogarth | Chicago, IL | Pulmonary Disease | $46,144.49 |
| Michael Pritchett | Pinehurst, NC | Pulmonary Disease | $41,554.54 |
| Ashutosh Sachdeva | Baltimore, MD | Pulmonary Disease | $38,040.44 |
| David Feller Kopman | Baltimore, MD | Critical Care Medicine (Internal Medicine) | $32,161.75 |
| Kamran Ayub | Oak Lawn, IL | Gastroenterology (Internal Medicine) | $31,785.99 |
| Adam Goodman | Brooklyn, NY | Gastroenterology (Internal Medicine) | $28,583.09 |
| Amit Mahajan | Falls Church, VA | Internal Medicine | $21,893.36 |
| Tareq Aro | New Hyde Park, NY | $20,346.52 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.